–
Acurx Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−12.1
FY23:
−14.6
FY24:
−14.1
FY25:
−8.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−12.1
FY23:
−14.6
FY24:
–
FY25:
−8.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.7
FY22:
−12.1
FY23:
−14.6
FY24:
–
FY25:
−7.97
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.7
FY22:
−12.1
FY23:
−14.6
FY24:
−14.1
FY25:
−7.97
All amounts in millions USD